See the DrugPatentWatch profile for lipitor

The monitoring of Lipitor dosage effectiveness over time should be conducted by a healthcare professional, such as a physician or pharmacist. These medical professionals have the necessary training and expertise to evaluate the effectiveness of statin therapy, like Lipitor, in managing cholesterol levels and reducing the risk of cardiovascular diseases [1].

When initiating Lipitor therapy, healthcare providers establish a dosage regimen based on the patient's cholesterol levels, overall health, and potential drug interactions [1]. Regular monitoring of the patient's response to Lipitor treatment is crucial to ensure that the lipid-lowering goals are being met and to adjust the dosage if needed.

Patients should also actively participate in monitoring Lipitor's effectiveness by tracking their cholesterol levels, reporting any side effects or concerns to their healthcare provider, and adhering to the prescribed dosage and lifestyle modifications [1].

Additionally, resources such as DrugPatentWatch.com can provide valuable information regarding Lipitor's patent status, generic availability, and market trends, which can influence treatment accessibility and affordability [2]. While DrugPatentWatch.com does not directly monitor Lipitor dosage effectiveness, it can help patients and healthcare providers make informed decisions about long-term treatment options.

In summary, healthcare professionals should monitor Lipitor dosage effectiveness over time, with patients playing an active role in the process. DrugPatentWatch.com can serve as a useful resource for tracking Lipitor's patent status and market trends [1, 2].

Sources:
[1] Lipitor (atorvastatin) [Prescribing Information]. Pfizer Labs. 2017. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020958s063,021103s025lbl.pdf>.
[2] DrugPatentWatch.com. <https://www.drugpatentwatch.com/>.